ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,381.35
0.33%
Dow Jones
39,216.61
0.41%
Gold vs US Dollar
2,330.145
0.95%
Brent Oil
83.535
-0.03%
Bitcoin
62,367.23
1.92%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. 180 Life Sciences Corporation (ATNF)

  7. 180 Life Sciences Corporation (ATNF) News

180 Life Sciences (ATNF)

180 Life Sciences Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ATNF
DateTimeSourceHeadlineSymbolCompany
14/03/202412:30GlobeNewswire Inc.180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:ATNF180 Life Sciences Corporation
11/03/202411:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
08/03/202421:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
29/02/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
28/02/202411:42Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
28/02/202411:39Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
28/02/202411:37Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
28/02/202411:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
26/02/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
26/02/202412:00GlobeNewswire Inc.180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance PlanNASDAQ:ATNF180 Life Sciences Corporation
20/02/202413:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
16/02/202422:10Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
16/02/202422:08Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
16/02/202422:05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
16/02/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
12/02/202421:15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
31/01/202422:29Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ATNF180 Life Sciences Corporation
29/01/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
17/01/202413:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
16/01/202413:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
28/12/202323:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATNF180 Life Sciences Corporation
27/12/202321:15Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ATNF180 Life Sciences Corporation
26/12/202321:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ATNF180 Life Sciences Corporation
21/12/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
20/12/202313:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
18/12/202321:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATNF180 Life Sciences Corporation
15/12/202313:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
14/12/202321:30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ATNF180 Life Sciences Corporation
04/12/202314:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
04/12/202314:00GlobeNewswire Inc.180 Life Sciences Engages Financial Advisor to Explore Strategic AlternativesNASDAQ:ATNF180 Life Sciences Corporation
 Showing the most relevant articles for your search:NASDAQ:ATNF

Your Recent History

LSE
TERN
Tern
LSE
POS
Plexus
LSE
SCE
Surface Transforms
LSE
KEFI
Kefi Gold And Copper
LSE
BIRD
Blackbird
LSE
GOLD
LSE
ITV
Itv
LSE
PET
Petrel Resources
LSE
AGL
Angle
LSE
SYME
Supply@me Capital
LSE
GWMO
Great Western Mining
LSE
GCM
Gcm Resources
LSE
BOO
Boohoo
LSE
AAU
Ariana Resources
LSE
UPS
LSE
GDR
Genedrive
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved